Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep 1;2(9):e25620.
doi: 10.4161/onci.25620. Epub 2013 Jul 9.

Mutations in glioblastoma oncosuppressive pathways pave the way for oncomodulatory activity of cytomegalovirus

Affiliations

Mutations in glioblastoma oncosuppressive pathways pave the way for oncomodulatory activity of cytomegalovirus

Todd C Hollon et al. Oncoimmunology. .

Abstract

Over the last decade, cytomegalovirus (CMV) has been suggested to promote the development of glioblastoma multiforme (GBM). Recent evidence demonstrates that CMV contributes to the progression of GBM in the context of oncosuppressor gene mutations. This finding provides further insights into the mechanisms whereby CMV exacerbates the malignancy of GBM.

Keywords: brain tumor; glioma; rhabdomyosarcoma; tumor suppressor genes; viral oncology.

PubMed Disclaimer

Figures

None
Figure 1. Mechanisms of STAT3 activation by CMV. Cytomegalovirus (CMV) can activate signal transducer and activator of transcription 3 (STAT3) in glioblastoma multiforme (GBM) cells by 3 different mechanisms. CMV-infected cells secrete increased levels of interleukin-6 (IL-6), stimulating signal transduction via the IL-6 receptor (IL6R)-STAT3 axis. US28 is a CMV-encoded constitutively active chemokine receptor that is capable of activating STAT3. The CMV virion can activate STAT3 via platelet-derived growth factor receptor α chain (PDGFRα), presumably by means of the viral surface glycoprotein B. The combination of STAT3 activation and oncosuppressor gene loss significantly exacerbates the malignancy of GBM cells.

Similar articles

Cited by

References

    1. Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, et al. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res. 2002;62:3347–50. - PubMed
    1. Sampson JH, Mitchell DA. Is cytomegalovirus a therapeutic target in glioblastoma? Clin Cancer Res. 2011;17:4619–21. doi: 10.1158/1078-0432.CCR-11-0992. - DOI - PubMed
    1. Michaelis M, Doerr HW, Cinatl J. The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia. 2009;11:1–9. - PMC - PubMed
    1. Price RL, Song J, Bingmer K, Kim TH, Yi JY, Nowicki MO, et al. Cytomegalovirus contributes to glioblastoma in the context of tumor suppressor mutations. Cancer Res. 2013;73:3441–50. doi: 10.1158/0008-5472.CAN-12-3846. - DOI - PMC - PubMed
    1. Price RL, Bingmer K, Harkins L, Iwenofu OH, Kwon CH, Cook C, et al. Cytomegalovirus infection leads to pleomorphic rhabdomyosarcomas in Trp53+/- mice. Cancer Res. 2012;72:5669–74. doi: 10.1158/0008-5472.CAN-12-2425. - DOI - PMC - PubMed

LinkOut - more resources